News
Interferon treatment is beneficial in early multiple sclerosis
BMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7265.851/a (Published 07 October 2000) Cite this as: BMJ 2000;321:851
- Fred Charatan
- Florida
Treatment with interferon beta-1a (Avonex) reduced the rate of development of multiple sclerosis in patients with early signs of the disease by about a half, a study in the New England Journal of Medicine has shown (NEJM 2000;343:898-904).
The study was carried out at 50 US and Canadian hospitals on 383 patients, each of whom had at least one episode of neurological symptoms indicating …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.